RGNX - Financial Reports List - REGENXBIO Inc. - IntrinsicAlpha

REGENXBIO Inc. RGNX

Healthcare - Biotechnology - NASDAQ - US

$ 9.86

-3.6 %

$ 495 M

Market Cap

-3.12

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	469.79%	109.61%	119.64%
Quarterly Report	Q4	8-K	2024-12-31	-4.50%	18.61%	19.62%
Annual Report	FY	10-K	2024-12-31	-7.66%	13.81%	12.97%
Quarterly Report	Q3	8-K	2024-09-30	-16.31%	3.67%	4.44%
Quarterly Report	Q2	8-K	2024-06-30	11.60%	26.47%	23.35%
Quarterly Report	Q1	8-K	2024-03-31	-18.37%	9.46%	6.64%
Quarterly Report	Q4	8-K	2023-12-31	-29.13%	-4.93%	-10.61%
Annual Report	FY	10-K	2023-12-31	-19.94%	6.00%	-2.00%
Quarterly Report	Q3	8-K	2023-09-30	9.06%	22.59%	8.56%
Quarterly Report	Q2	8-K	2023-06-30	-38.81%	-5.69%	-16.91%

1